The pharmaceutical industry is coming out with new product and therapeutic innovations at a rapid pace. For example, cell and gene therapy is one of the many areas exploding with possibilities for novel treatments of formerly life-threatening conditions. The pressure to bring these new treatments to market quickly, efficiently, and with dependable quality has increased accordingly. Alongside this explosion of innovative solutions is an expectation to continuously improve your products and processes.
The Product Development and Product Systems track at the 2018 ISPE Annual Meeting & Expo in Philadelphia, PA, USA will address this paradigm shift with sessions and workshops presented by experienced practitioners who will share their experiences and solutions to today’s challenges.
The Product Development and Product Systems track will explore how new technologies and thinking will change the product development and manufacturing processes, and their impact on the future state of the industry, through the integration of:
The following topics will be covered:
The Product Development and Product Systems track team looks forward to meeting with you in Philadelphia this November to discuss challenges and share knowledge and solutions.
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...